|
In Vitro Activity of the New Azole Isavuconazole (BAL 4815) Compared with Six other Antifungal Agents against 155 Cryptococcus neoformans Isolates from Cuba (click for details) |
|
|
|
In Vitro Activity of the New Azole BAL4815 and other Antifungal Agents against Candida Bloodstream Isolates (click for details) |
|
|
|
Candida Krusei in Surgical Site Infection: Evidence for a Clonal Outbreak in Transplant and Non Transplant Patients.
(click for details) |
|
|
|
In Vitro Inhibitory and Fungicidal Properties of EDTA for Aspergillus and Fusarium Species. (click for details) |
|
|
|
Study of Susceptibility to Posaconazole (POS) and Caspofungin (CAS) in Invasive Yeast Strains (IYS) Isolated from Blood Cultures and CSF During Two Years in a Spanish University Hospital: Evaluation of the POS and CAS Etest.
(click for details) |
|
|
|
Flucytosine (5-FC) Levels: 15-years Experience from the United Kingdom.
(click for details) |
|
|
|
Efficacy of Abelcet in a Rabbit Model of Coccidioidal Meningitis.
(click for details) |
|
|
|
Evaluating Voriconazole (VCZ) as Primary Antifungal Prophylaxis During Induction Chemotherapy for Acute Myelogenous Leukemia (AML).
(click for details) |
|
|
|
Concomittant N-Acetylcystein for the Prevention of the Amphotericin B Induced Renal Tubular Apoptosis.
(click for details) |
|
|
|
In Vitro Activities of Statins (Anti-Cholesterol Drugs) Alone and in Combination with Antifungal Drugs against Aspergillus Species.
(click for details) |
|
|
